Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TelyRx HoldingsTSX:TELY +13.04%12 Days Inventory is 13.69 as of Mar. 2026, which is 19% below its 10-year median of 17.00. GuruFocus rates TSX:TELY with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 494 Healthcare Providers & Services companies, TelyRx Holdings ranks better than 59.11% on this metric.
The historical rank and industry rank for TelyRx Holdings's Days Inventory or its related term are showing as below:
TSX:TELY'
s Days Inventory Range Over the Past 10 Years
Min: 15.68 Med: 17 Max: 906.97
Current: 21.92
During the past 3 years, TelyRx Holdings's highest Days Inventory was 906.97. The lowest was 15.68. And the median was 17.00.
TSX:TELY's Days Inventory is ranked better than 59.11% of 494
companies
in the Healthcare Providers & Services industry
Industry Median: 29.325
vs TSX:TELY: 21.92
TelyRx Holdings's Days Inventory
declined
from Dec. 2024 (15.88) to Mar. 2026 (13.69).
Inventory Turnover measures how fast the company turns over its inventory within a year.
TelyRx Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 was 6.67.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
TelyRx Holdings's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.07.
TelyRx Holdings (TSX:TELY) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
TelyRx Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
TelyRx Holdings's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
TelyRx Holdings Days Inventory Related Terms
TelyRx Holdings Days Inventory Historical Data
* Premium members only.
The historical data trend for TelyRx Holdings's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TelyRx Holdings Days Inventory Competitor Comparison
For the Pharmaceutical Retailers subindustry, TelyRx Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TelyRx Holdings Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TelyRx Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where TelyRx Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TelyRx Holdings (TSX:TELY) has a Days Inventory of 13.69 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on TelyRx Holdings and its competitors. This is 19% below median its historical median of 17.00. Over the past decade, TelyRx Holdings' Days Inventory has ranged from 15.68 to 906.97. According to the industry distribution chart, TelyRx Holdings ranks #202 out of 494 companies in the Healthcare Providers & Services industry, placing it in the top 40.9%.
Is TelyRx Holdings' Days Inventory too high?
TelyRx Holdings' current Days Inventory of 13.69 is 19% below median its 10-year median of 17.00. Over the past 10 years, this metric has ranged from a low of 15.68 to a high of 906.97. The Healthcare Providers & Services industry median Days Inventory is 29.33. TelyRx Holdings' value of 13.69 is 53.3% below this industry median. Based on the distribution chart, TelyRx Holdings ranks #202 out of 494 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, TelyRx Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does TelyRx Holdings' Days Inventory compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, TelyRx Holdings ranks #202 out of 494 companies for Days Inventory. This puts TelyRx Holdings in the upper half of its industry. The industry median Days Inventory is 29.33. TelyRx Holdings' value of 13.69 is 53.3% below this benchmark. Historically, TelyRx Holdings' own Days Inventory has ranged from 15.68 to 906.97 over the past decade. While the company's 10-year median is 17.00 vs. the industry median of 29.33, TelyRx Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 29.33, based on 494 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TelyRx Holdings's current Days Inventory of 13.69 is 53.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on TelyRx Holdings and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 29.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TelyRx Holdings's current Days Inventory is 13.69, which is 19% below median its own 10-year median of 17.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TelyRx Holdings stock overvalued right now?
TelyRx Holdings (TSX:TELY) has a current Days Inventory of 13.69. The current Days Inventory is 13.69, which is 19% below median its 10-year median of 17.00 and 53.3% below the Healthcare Providers & Services industry median of 29.33. TelyRx Holdings' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For TelyRx Holdings (TSX:TELY), the current Days Inventory is 13.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TelyRx Holdings Inc is a vertically integrated technology enabled healthcare and pharmacy services provider, operating a digital pharmacy platform that connects patients with independent, state-licensed providers. The TelyRx platform provides the Providers with access to a clinically focused electronic medical records system and the ability for them to electronically prescribe. TelyRx enables patient access to a risk-curated formulary of over 450 noncontrolled, and non-compounded prescription medications selected by the Providers to address a broad cross-section of everyday chronic and acute ailments.
12GF Score
Get the complete analysis for TSX:TELY
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:TELY has been successfully added to your 
